TI   "Medical Briefs"
 AU   Daubenmier, Judy
 SO   Advocate (12/28/93) No. 635, P. 36
 AB   Upjohn Laboratories has produced a drug that has been found in the
      laboratory to be an effective HIV-inhibiting protease during the late
      stages of viral replication.  The drug, U-75875, dramatically
      decreased HIV replication in both monocytes and chronically infected
      cells.  Other drugs tested were only effective in newly infected
      cells.  A report on the study proposes that the use of protease
      inhibitors alone or with another drug is important for HIV therapy.

      Copyright (c) 1993 - Information, Inc., Bethesda, MD.  This
      information is provided by the Centers for Disease Control &
      Prevention (CDC), National AIDS Clearinghouse as a public service. 
      Non-profit reproduction is encouraged.

 * Origin: AEGIS/San Juan Capistrano 714.248.2836 (CASAN)  (1:103/927)
 * Provided as a service of THE BACKROOM - NYC * 718-951-8256